- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 69.6M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $151.29M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $151.18M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $231.56M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $231.18M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $142.36M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $341.97M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $249.65M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $339.56M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $325.85M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $514.73M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $493.72M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $422.72M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $465.65M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $891.54M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $858.93M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 58.59M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $208K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $10.27M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $357.21M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $366.92M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.35 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.35 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $14.56M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $14.87M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$20.59M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$22.81M |
| Revenue | Q1 2025 · Mar 31, 2024 | $74.72M |